Poland – Pharmaceutical products

Original title (Polish): Poland – Pharmaceutical products – Dostawa produktów leczniczych z grupy: Leki dostępne w ramach programu lekowego; Leki, stosowane w ramach chemioterapii w całym zakresie zarejestrowanych wskazań i przeznaczeń oraz we wskazaniu określonym stanem klinicznym; leki przeciwnowotworowe i immunomodulujące oraz immunoglobuliny niespecyficzne (zgodnie z klasyfikacją ATC) – z listy 31 pakietów

Dolnośląskie Centrum Onkologii, Pulmonologii I Hematologii · Poland government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

September 29, 2026
Response Due
Active
Status

Opportunity Overview

fiol. 10 mg | fiol. 500 mg | fiol. 20 mg | fiol. 10 mg/10 ml | tabl. 100 mg | kaps. 1 mg | amp. 5 mg/1 ml | tabl.powl. 40 mg | fiol. 100 mg | fiol. 100 mcg/0,5 ml | fiol. 200 mg, proszek do sporządzania koncentratu roztworu do infuzji | fiol. 100 mg, koncentrat do sporządzania roztworu do infuzji | fiol. 140 mg, proszek do sporządzania koncentratu roztworu do infuzji | ampułkostrzykawka 135 mcg/0,5ml | kapsułki miękkie 150 mg | tabl. powl. 500 mg | tabl. powl. 100 mg | fiol.10 g/100ml | fiol. 5 g/50ml | fiol. 500 mg/10 ml | fiol.120 mg/1,7 ml | fiol. 1800mg/15ml | tabl. powl. 300 mg | fiol. 2000 mg | fiol.350 mg | tabl.powl. 20 mg lub tabl.powl. 40 mg lub tabl.powl. 60 mg | tabl. powl. 200 mg, tabl. powl.50 mg / tabl. powl. 200 mg, tabl.powl. 150 mg | kaps. twarde, 300+0,5 mg | fiol. 100 mg/6ml

This Poland Pharmaceuticals opportunity is one most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyDolnośląskie Centrum Onkologii, Pulmonologii I Hematologii
CountryPoland
CategoryPharmaceuticals
PublishedAugust 25, 2026
Procurement stageRequest for Proposal (RFP)
Response dueSeptember 29, 2026
StatusOpen — accepting responses
Original languagePolish — members read it in their own language
Official sourceView original notice
Last verifiedSeptember 20, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Poland

Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products

See every Poland Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Poland Pharmaceuticals intelligence report in your inbox

A personalized report on Poland Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.